Detalhe da pesquisa
1.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Circulation
; 137(9): 961-972, 2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483172
2.
Statistical inference problems in sequential parallel comparison design.
J Biopharm Stat
; 29(6): 1116-1129, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31035859
3.
Rejoinder to "Statistical inference problems in sequential parallel comparison designs".
J Biopharm Stat
; 29(6): 1134-1136, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31032707
4.
Commentary on "Applying CHW method to 2-in-1 design: gain or lose".
J Biopharm Stat
; 29(4): 722-727, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31258011
5.
Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials.
J Biopharm Stat
; 26(1): 37-43, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366624
6.
Multiplicity in confirmatory clinical trials: a case study with discussion from a JSM panel.
Stat Med
; 34(26): 3461-80, 2015 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112381
7.
Some challenges with statistical inference in adaptive designs.
J Biopharm Stat
; 24(5): 1059-72, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24915027
8.
A regulatory perspective on essential considerations in design and analysis of subgroups when correctly classified.
J Biopharm Stat
; 24(1): 19-41, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24392976
9.
Multiple comparisons in complex clinical trial designs.
Biom J
; 55(3): 420-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23620458
10.
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis plan.
Biom J
; 55(3): 275-93, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553537
11.
Paradigms for adaptive statistical information designs: practical experiences and strategies.
Stat Med
; 31(25): 3011-23, 2012 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927234
12.
Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
J Biopharm Stat
; 22(5): 1037-50, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22946948
13.
Flexible design clinical trial methodology in regulatory applications.
Stat Med
; 30(13): 1519-27, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21344470
14.
Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
J Biopharm Stat
; 21(4): 846-59, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21516573
15.
Rejoinder to Dr. Cyrus R. Mehta.
J Biopharm Stat
; 26(2): 405, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467176
16.
Methods for Employing Information About Uncertainty of Ascertainment of Events in Clinical Trials.
Ther Innov Regul Sci
; 55(1): 197-211, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870460
17.
On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes.
Contemp Clin Trials
; 101: 106244, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309946
18.
University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (afternoon panel discussion session).
Clin Trials
; 12(4): 365-73, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26178573
19.
Consideration of regional difference in design and analysis of multi-regional trials.
Pharm Stat
; 9(3): 173-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20872619
20.
Trial design issues and treatment effect modeling in multi-regional schizophrenia trials.
Pharm Stat
; 9(3): 217-29, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20872622